Schedule 13G ownership disclosure

CALIDI BIOTHERAPEUTICS INC

Security class unavailable · CUSIP: 320703119

Event date: 2023-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
12,500
Percent of class
0.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001085146-24-000948
Form type
SC 13G
Filer
BANK OF MONTREAL /CAN/
CIK
CIK 927971
Filed
Feb 09, 2024
Reporting period
Dec 31, 2023
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub